- Home
- WPM vs HLN Comparison
WPM vs HLN Comparison
Compare WPM & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WPM | HLN |
|---|---|---|
| Founded | 2004 | 2022 |
| Country | Canada | United Kingdom |
| Employees | N/A | N/A |
| Industry | Precious Metals | Package Goods/Cosmetics |
| Sector | Basic Materials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.3B | 44.5B |
| IPO Year | 2004 | N/A |
Fundamental Metrics
Financial Performance| Metric | WPM | HLN |
|---|---|---|
| Price | $126.00 | $10.25 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 1 |
| Target Price | ★ $132.50 | N/A |
| AVG Volume (30 Days) | 1.7M | ★ 9.2M |
| Earning Date | 11-06-2025 | 02-26-2026 |
| Dividend Yield | 0.55% | ★ 1.79% |
| EPS Growth | ★ 64.06 | 41.64 |
| EPS | ★ 2.20 | 0.23 |
| Revenue | $1,830,402,000.00 | ★ $15,096,588,575.00 |
| Revenue This Year | $64.33 | $1.51 |
| Revenue Next Year | $22.83 | $4.67 |
| P/E Ratio | $54.91 | ★ $44.20 |
| Revenue Growth | ★ 50.33 | N/A |
| 52 Week Low | $55.51 | $8.71 |
| 52 Week High | $125.62 | $11.42 |
Technical Indicators
Market Signals| Indicator | WPM | HLN |
|---|---|---|
| Relative Strength Index (RSI) | 67.03 | 67.01 |
| Support Level | $114.51 | $9.88 |
| Resistance Level | $124.30 | $10.15 |
| Average True Range (ATR) | 3.67 | 0.12 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 99.16 | 89.68 |
Price Performance
Historical ComparisonAbout WPM Wheaton Precious Metals Corp (Canada)
Wheaton Precious Metals Corp is a precious metal streaming company. Its reportable segment includes: Gold, Silver, Palladium, Platinum, Cobalt, and Other. It generates its revenue from the sale of precious metals (gold, silver and palladium) and cobalt.
About HLN Haleon plc (Each representing two)
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.